The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers.
Ovarian and pancreatic cancers are two of the most aggressive and lethal cancers, whose management faces only limited therapeutic options. Typically, these tumors spread insidiously accompanied first with atypical symptoms, and usually shift to a drug resistance phenotype with the current pharmaceut...
Saved in:
| Main Authors: | Lucie Carolle Kenmogne, Diana Ayan, Jenny Roy, René Maltais, Donald Poirier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144890&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models.
by: Lucie Carolle Kenmogne, et al.
Published: (2017-01-01) -
Development of a Multigram Synthetic Route to RM-581, an Orally Active Aminosteroid Derivative Against Several Types of Cancers
by: René Maltais, et al.
Published: (2025-06-01) -
Synthesis of 19-Norsteroids V: 13-Aminosteroids
by: D.B.R. Johnston, et al.
Published: (1968-02-01) -
Antiprotozoal Aminosteroids from <i>Pachysandra terminalis</i>
by: Lizanne Schäfer, et al.
Published: (2025-02-01) -
Effect of Aminosteroid U74389G in a Model of Inflammatory Bowel Disease in Rats
by: Plamen Krastev, et al.
Published: (2021-12-01)